EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights

Ce Kang, Rajasumi Rajalingam, Zachary Walls, Jana Huang, Christine Sun, Laura I Rudaks iD, Dennis Yeow iD, Ashar Rasheed, Jenny W Zhang, Moath Hamed, Marianthi Breza iD, Susen Schaake und 13 weitere

Movement Disorders Clinical Practice · 2026

DOI: 10.1002/mdc3.70559 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Movement Disorders Clinical Practice, 2026. Verfasst von Ce Kang und 24 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Spastin, GTP-Binding Proteins, Membrane Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder characterized by progressive spasticity and lower limb weakness. The most common forms of autosomal dominant HSP are caused by pathogenic variants in SPAST (SPG4 or HSP‐ SPAST ), ATL1 (SPG3A or HSP‐ ATL1 ), and REEP1 (SPG31 or HSP‐ REEP1 ).

Objectives

We performed an MDSGene Systematic Review to determine in‐depth genotype–phenotype associations and to estimate longitudinal progression, to inform prognostication and clinical trial stratification.

Methods

We systematically collected demographic, phenotypic, and genetic data from published reports of individuals affected by these forms of HSP using the MDSGene protocol.

Results

We reviewed 2177 affected individuals, including 1670 individuals with HSP‐ SPAST , 356 with HSP‐ ATL1 and 151 with HSP‐ REEP1 . HSP‐ ATL1 was associated with an earlier age at onset compared to HSP‐ SPAST and HSP‐ REEP1 . Toe‐walking was more frequently reported in HSP‐ ATL1 (10.4%) and HSP‐ REEP1 (3.3%) than HSP‐ SPAST (0.3%). Upper limb hyperreflexia and abnormalities of bladder function were more frequent in HSP‐ SPAST than HSP‐ ATL1 or HSP‐ REEP1 . Sufficient data was available to estimate disease progression for HSP‐ SPAST ; this showed that Spastic Paraplegia Rating Scale (SPRS) scores increased with increasing age at examination after the age of 40 years. Truncating variants were more frequent in HSP‐ SPAST and HSP‐ REEP1 than HSP‐ ATL1 .

Conclusion

Overall, HSP‐ ATL1 , HSP‐ SPAST and HSP‐ REEP1 demonstrated differences in clinical phenotypes. To our knowledge, this is the first systematic review to model longitudinal progression using SPRS scores in HSP. Missing data is a limiting factor in all these comparisons, highlighting the need for uniform data collection. Online resources can be found at https://www.mdsgene.org/ .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditarySpastinGTP-Binding ProteinsMembrane ProteinsMembrane Transport ProteinsHumansGenetic Association StudiesDisease Progression

Stichwörter der Autor:innen

ATL1atlastinautosomal dominanthereditary spastic paraplegiaspastspastin

Substanzen

SpastinATL1 protein, humanSPAST protein, humanGTP-Binding ProteinsREEP1 protein, humanMembrane ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
  • The Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
  • Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA.
  • Faculty of Engineering and Information Technologies, University of Sydney, Darlington, NSW, Australia.
  • ANZAC Research Institute, Department of Neurology and Molecular Medicine Laboratory, Concord Repatriation General Hospital and Sydney Local Health District, Concord, NSW, Australia.
  • Translational Neurogenomics Group, Garvan Institute for Medical Research, Darlinghurst, NSW, Australia.

ORCID-Profile: Laura I Rudaks, Dennis Yeow, Marianthi Breza, Connie Marras, Kishore R Kumar

Zitieren

APA

Kang, C., Rajalingam, R., Walls, Z., Huang, J., Sun, C., Rudaks, L. I., Yeow, D., Rasheed, A., Zhang, J. W., Hamed, M., Breza, M., Schaake, S., Vekhande, C., Massa, J., Massa, R. E., Shetty, A., Sue, C. M., Cambi, F., Suchowersky, O., …, & Kumar, K. R. (2026). MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70559

Vancouver

Kang C, Rajalingam R, Walls Z, Huang J, Sun C, Rudaks LI, et al. MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70559

BibTeX
@article{Kang2026,
  author = {Kang, Ce and Rajalingam, Rajasumi and Walls, Zachary and Huang, Jana and Sun, Christine and Rudaks, Laura I and Yeow, Dennis and Rasheed, Ashar and Zhang, Jenny W and Hamed, Moath and Breza, Marianthi and Schaake, Susen and Vekhande, Chetan and Massa, Jason and Massa, Robyn E and Shetty, Aakash and Sue, Carolyn M and Cambi, Franca and Suchowersky, Oksana and Vulinovic, Franca and Petkovic, Sonja and Klein, Christine and Lohmann, Katja and Marras, Connie and Kumar, Kishore R},
  title = {MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70559}
}
Kostenlos starten →